2023 Form 5500 filing — Madrigal Pharmaceuticals, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241014164003NAL0013635283001) for Madrigal Pharmaceuticals, Inc. 401(K) Plan, reported by Madrigal Pharmaceuticals, Inc. under EIN 04-3508648 and plan number 001. It reports 134 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241014164003NAL0013635283001
Filing year
2023
Form type
2
Plan sponsor
Madrigal Pharmaceuticals, Inc.
EIN
04-3508648
Plan number
001
Location
West Conshohocken, PA
Participants
134
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$13,585,595
Total liabilities (EOY)
$0
Net assets (EOY)
$13,585,595
Employer contributions
$663,656
Participant contributions
$2,124,937
Total income / additions
$5,661,730
Benefits paid
$664,513
Administrative expenses
$4,094
Total expenses
$668,607
Net increase / (decrease)
$4,993,123
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Commonwealth Financial NetworkADVISOR$0$24,326
Fidelity Investments InstitutionalRECORDKEEPER$4,094$0

Related Form 5500 pages